Skip to main content
. 2019 Jul 1;9:9468. doi: 10.1038/s41598-019-45990-7

Table 2.

Lung function assessment in the SSc patients at baseline.

Parameter All patients (n = 83) ILD+ (n = 39) ILD− (n = 44) p*
Arterial pO2 (mmHg) at rest (21% FiO2) 83.7 ± 11.8 83 ± 2.2 84.2 ± 1.8 0.6
Arterial SpO2 (%) (median, range) 98.2 (83.5–100) 97.9 (83.5–99.5) 98.3 (95.3–100) 0.37
FVC (% predicted) 99.7 ± 25 89.2 ± 26.0 107.8 ± 21.2 0.001
TLC (% predicted) 80.9 ± 18.2 75.4 ± 20.9 85.6 ± 14.1 0.021
RV (% predicted) 78.5 ± 26.7 61.7 ± 3.6 91.7 ± 4.3 <0.001
DLCOsb (% predicted) 59 ± 19.4 51.2 ± 18.9 65.4 ± 17.5 0.001
6MWT distance (mt) (median, range) 440 (176–566) 426 (264–528) 462 (176–566) 0.24
6MWT ΔSpO2 (%) (median, range) 2 (0–18) 3 (0–18) 1 (0–14) 0.002

Data are expressed as mean ± standard deviation, except where otherwise indicated.

SSc = systemic sclerosis; ILD = interstitial lung disease; pO2 = oxygen partial pressure; FiO2 = fraction of inhaled oxygen; SpO2 = oxygen saturation; FVC = forced vital capacity; TLC = total lung capacity; RV = residual volume; DLCOsb = single breath diffusion lung capacity for carbon monoxide; 6MWT = six-minute walk test; mt = meters.

*p is ILD+ versus ILD−.